ADMA Biologics Inc (NASDAQ:ADMA)
| 2.07 Delayed Data As of 4:00pm ET |  -0.07 / -3.27%Today’s Change | 1.01 Today|||52-Week Range 2.38 | +46.81% Year-to-Date |
Latest ADMA News | Press Releases
| Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for 10:00am / Zacks.com - Paid Partner Content | Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates Aug 03 / Zacks.com - Paid Partner Content |
| Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Aug 03 / Zacks.com - Paid Partner Content | Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates Jul 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.14 |
| Today’s open | 2.13 |
| Day’s range | 2.05 - 2.18 |
| Volume | 94,024 |
| Average volume (3 months) | 2,703,524 |
| Market cap | $420.2M |
Data as of 4:00pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | +41.62% |
| Earnings growth (this year) | +34.64% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +91.72% |
| P/E ratio | NM |
| Price/Sales | 2.43 |
| Price/Book | 2.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PGENPrecigen Inc | 0.00 | 0.00% |
| XXII22nd Century Group I... | +0.04 | +1.74% |
| ALDXAldeyra Therapeutics... | +0.29 | +4.19% |
| ---- |
Data as of 4:00pm ET, 08/08/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$71.6M |
| Net profit margin | -88.52% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ramsey, New Jersey |
Forecasts
